A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).

Clinical trial NCT05578872 · COMPLETED

Trial details

NCT number: NCT05578872
Sponsor: Anaveon AG
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)Cutaneous Melanoma Adult Disease Advanced Solid Tumor Metastatic Melanoma

Start date: 2022-12-16
Primary completion: 2024-08-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.